Today

Agents

Chat

Arena

Discover

More

App

Canaccord Genuity raises Celldex Therapeutics target price to $68 from $60

CLDX•2026-11-06

Canaccord Genuity raised its target price for Celldex Therapeutics to $68 from $60.

Related News

V

Veeva Systems: UBS raises target price to $325 from $290

VEEV•2026-11-06

BlackRock increases total voting rights in Commerzbank to 4.44% from 4.38%

BLK•2026-11-06

Nasdaq trade halt: volatility trading pause at 9:52 a.m.

OMH•2026-11-06

Orange partners with Morrison on planned joint venture to develop five French data centers

ORAN•2026-11-06

Teradata Corporation: UBS raises target price to $35 from $32

TDC•2026-11-06

Canaccord Genuity raises Celldex Therapeutics target price to $68 from $60 - CLDX News | Rallies